THERAVANCE BIOPHARMA INC's ticker is and the CUSIP is G8807B956. A total of 2 filers reported holding THERAVANCE BIOPHARMA INC in Q2 2024. The put-call ratio across all filers is - and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| SIMPLEX TRADING, LLC | 1,500 | $12 | 0.00% |
This page lists THERAVANCE BIOPHARMA INC's shareholders in Q2 2024. To view THERAVANCE BIOPHARMA INC's shareholder history, click here.